medical devices- plastic surgery: aesthetic and reconstructive, urology
Company profile
Ticker
SIENQ
Exchange
Website
CEO
Jeffrey Nugent
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
SEC CIK
Corporate docs
Subsidiaries
miraDry Holdings, Inc. • miraDry, Inc. • miraDry International, Inc. • Miramar Labs HK Ltd. • miraDry International Sweden AB ...
SIENQ stock data
Latest filings (excl ownership)
8-K
Financial Statements and Exhibits
18 Apr 24
25-NSE
Exchange delisting
9 Apr 24
NT 10-K
Notice of late annual filing
29 Mar 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
13 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
8-K
Entry into a Material Definitive Agreement
16 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Dec 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Sientra Reports THIRD Quarter FINANCIAL and operational Results
9 Nov 23
Transcripts
SIENQ
Earnings call transcript
2023 Q3
9 Nov 23
SIENQ
Earnings call transcript
2023 Q2
10 Aug 23
SIENQ
Earnings call transcript
2023 Q1
11 May 23
SIENQ
Earnings call transcript
2022 Q4
30 Mar 23
SIENQ
Earnings call transcript
2022 Q3
11 Nov 22
SIENQ
Earnings call transcript
2022 Q2
12 Aug 22
SIENQ
Earnings call transcript
2022 Q1
13 May 22
SIENQ
Earnings call transcript
2021 Q4
23 Mar 22
SIENQ
Earnings call transcript
2021 Q3
11 Nov 21
SIENQ
Earnings call transcript
2021 Q2
11 Aug 21
Latest ownership filings
SC 13G/A
Rosalind Advisors, Inc.
20 Feb 24
SC 13G
WELLS FARGO & COMPANY/MN
6 Feb 24
4
Ronald Menezes
14 Nov 23
4
Hove Caroline F. Van
14 Nov 23
4
Oliver Christian Bennett
11 Sep 23
4
Andrew C Schmidt
7 Aug 23
4
PHILIPPE SCHAISON
20 Jun 23
4
MARY FISHER
20 Jun 23
4
Irina Erenburg
20 Jun 23
4
Nori Ebersole
20 Jun 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 15.63 mm | 15.63 mm | 15.63 mm | 15.63 mm | 15.63 mm | 15.63 mm |
Cash burn (monthly) | 1.20 mm | 303.17 k | 4.92 mm | 5.13 mm | 1.12 mm | 947.92 k |
Cash used (since last report) | 8.28 mm | 2.09 mm | 33.87 mm | 35.31 mm | 7.72 mm | 6.52 mm |
Cash remaining | 7.35 mm | 13.55 mm | -18.24 mm | -19.68 mm | 7.91 mm | 9.11 mm |
Runway (months of cash) | 6.1 | 44.7 | -3.7 | -3.8 | 7.1 | 9.6 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 34 |
Opened positions | 4 |
Closed positions | 12 |
Increased positions | 8 |
Reduced positions | 9 |
13F shares | Current |
---|---|
Total value | 4.70 bn |
Total shares | 22.81 mm |
Total puts | 27.70 k |
Total calls | 17.50 k |
Total put/call ratio | 1.6 |
Largest owners | Shares | Value |
---|---|---|
Flynn James E | 16.55 mm | $64.39 mm |
Clarus Lifesciences I | 2.73 mm | $0.00 |
Integrated Core Strategies | 1.27 mm | $4.94 mm |
Rosalind Advisors | 509.27 k | $0.00 |
WFC Wells Fargo & Co. | 402.02 k | $1.12 bn |
Vanguard | 329.59 k | $916.27 mm |
RTW Investments | 304.04 k | $845.22 mm |
HighTower Advisors | 95.32 k | $265.00 mm |
Geode Capital Management | 94.89 k | $263.86 mm |
BLK Blackrock | 81.61 k | $226.88 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Nov 23 | Van Hove Caroline F. | Common Stock | Payment of exercise | Dispose F | No | No | 0.71 | 741 | 526.11 | 8,239 |
13 Nov 23 | Ronald Menezes | Common Stock | Payment of exercise | Dispose F | No | No | 0.71 | 3,625 | 2.57 k | 16,775 |
7 Sep 23 | Oliver Christian Bennett | Common Stock | Grant | Acquire A | No | No | 1.75 | 2,739 | 4.79 k | 23,100 |
3 Aug 23 | Schmidt Andrew C | Common Stock | Payment of exercise | Dispose F | No | No | 3.86 | 561 | 2.17 k | 46,956 |
News
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
20 Feb 24
12 Health Care Stocks Moving In Tuesday's Intraday Session
20 Feb 24
12 Health Care Stocks Moving In Monday's After-Market Session
19 Feb 24
12 Health Care Stocks Moving In Friday's Pre-Market Session
16 Feb 24
12 Health Care Stocks Moving In Thursday's Intraday Session
15 Feb 24